Global Single Cell Multi-Omics Market: Focus on Global Single Cell Multi-Omics Market by Product, Type, Workflow, End-User 15 Countries Mapping, and Competitive Landscape - Analysis and Forecast: 2019-2025
Hard copy option is available on any of the options above at an additional charge of $500. Please email us at [email protected] with your request.
Key Questions Answered in this Report:
The global single cell multi-omics industry analysis by BIS Research projects that the market was valued at $1.83 billion in 2018 and is anticipated to generate a value of $5.32 billion by 2025.
This growth has been primarily attributed to the major drivers in this market such as the increased need for non-invasive diagnosis, advancements in single cell sequencing technique and increase in adoption of personalized medicine. These individualized care regimes are improving quality of life of the patients and reducing economic, societal, and clinical burden, projecting a future of prosperity.
The applications of single cell multi-omics primarily include oncology, cell biology, neurology, stem cell and immunology, among others. Aside from the discovery of effective biomarkers for the development of efficient targeted drug therapy, single cell approach also facilitates gene expression and protein expression analyses in an individual cell. Research and academic organizations, biotechnology and biopharmaceutical companies, and diagnostic centers, among others, are prominent end users of single cell multi-omics solutions.
Expert Quote on Global Single Cell Multi-Omics Market
“North America is the leading contributor of the global single cell multi-omics market and contributed approximately 45.40% to the global market value in 2019. This region is anticipated to grow at a double digit CAGR, during the forecast period 2019-2025 and continue to dominate the market in 2025 as well. The Europe region also contributed a significant share of 26.52% to the market in 2019 and is anticipated to grow at a substantial CAGR, during the forecast period.”
Scope of the Market Intelligence on Global Single Cell Multi-Omics Market
This research report aims at answering various aspects of the global single cell multi-omics market with the help of the key factors driving the market, the restraints, and the current growth opportunities that are going to shape the future trajectory of the market expansion. The report includes an in-depth examination of the key players and recent developments taking place in this market. Moreover, the report includes chapters on market dynamics (market drivers, opportunities, and challenges) and industry analysis as well.
The research study highlights the factors governing the industry attractiveness with the Porter’s Five Forces Analysis for a comprehensive understanding of the global single cell multi-omics market. Moreover, the study includes detailed product mapping, market estimation, and analysis of key trends in multiple geographical regions, growth of single cell multi-omics market in each region for different applications, and the key strategies and developments by the prominent single cell multi-omics manufacturers and service providers.
Market Segmentation
The market has been segmented into ‘type’, ‘workflow’, ‘product’, ‘applications’, ‘end users’, and ‘region’. The scope of this report is centered upon conducting a detailed study of the products and services allied with the single cell multi-omics market. In addition, the study also includes the exhaustive information on the unmet needs, perception on the new products, competitive landscape, market share of leading manufacturers, growth potential of each service, application, technology, end user, region, and company, as well as other vital information with respect to global single cell multi-omics market.
Based on region, the global single cell multi-omics market is segmented into North America, Europe, Asia-Pacific, Latin America, and Rest-of-the-World (RoW). North America is the leading contributor to the global single cell multi-omics market and was responsible for a 45.8% share of the global market values in 2018. However, the Asia-Pacific region is expected to grow at the fastest pace among all other regions with double digit CAGR, during the forecast period 2019-2025.
Key Companies in the Global Single Cell Multi-Omics Market
The key players who have been contributing significantly to the global single cell multi-omics market include 10x Genomics, Inc., 1CellBio, MissionBio, NanoString Technologies, Inc., Fluidigm Corporation, Fluxion Biosciences, Bio-Rad Laboratories, Inc., Celsee, Inc., BGI Genomics Co. Ltd. GE LifeSciences, Illumina, Inc., and Takara Bio, QIAGEN N.V., among others.
Key Questions Answered in this Report:
- What was the total revenue generated by the global single cell multi-omics market and how is it expected to grow during 2019-2025?
- What are the major driving forces, trends, challenges and growth opportunities that can tend to increase the demand for the global single cell multi-omics market during the forecast period, 2019-2025?
- How each segment of the global single cell multi-omics market by 2025? What was the revenue generated by the global single cell multi-omics market by
- Type, such as single cell genomics market, single cell proteomics and transcriptomics market, and single cell metabolomics market in 2018?
- Product, such as systems & instruments and consumables in 2018?
- Workflow, such as single cell isolation, single cell preparation, and single cell analysis in 2018?
- Application, such as oncology, immunology, neurology, microbiology, stem cell, cell biology, and others in 2018?
- Region, such as North America, Europe, Asia-Pacific, Latin America, and Rest-of-the-World in 2018?
- Who are the key manufacturers and service providers in the global single cell multi-omics market, and what are their contributions?
- What is the growth potential of each major single cell multi-omics manufacturer and service provider?
- What are the key development strategies which are implemented by major players in order to sustain in the competitive market?
- What are the key regulatory implications in developed and developing regions for single cell multi-omics?
The global single cell multi-omics industry analysis by BIS Research projects that the market was valued at $1.83 billion in 2018 and is anticipated to generate a value of $5.32 billion by 2025.
This growth has been primarily attributed to the major drivers in this market such as the increased need for non-invasive diagnosis, advancements in single cell sequencing technique and increase in adoption of personalized medicine. These individualized care regimes are improving quality of life of the patients and reducing economic, societal, and clinical burden, projecting a future of prosperity.
The applications of single cell multi-omics primarily include oncology, cell biology, neurology, stem cell and immunology, among others. Aside from the discovery of effective biomarkers for the development of efficient targeted drug therapy, single cell approach also facilitates gene expression and protein expression analyses in an individual cell. Research and academic organizations, biotechnology and biopharmaceutical companies, and diagnostic centers, among others, are prominent end users of single cell multi-omics solutions.
Expert Quote on Global Single Cell Multi-Omics Market
“North America is the leading contributor of the global single cell multi-omics market and contributed approximately 45.40% to the global market value in 2019. This region is anticipated to grow at a double digit CAGR, during the forecast period 2019-2025 and continue to dominate the market in 2025 as well. The Europe region also contributed a significant share of 26.52% to the market in 2019 and is anticipated to grow at a substantial CAGR, during the forecast period.”
Scope of the Market Intelligence on Global Single Cell Multi-Omics Market
This research report aims at answering various aspects of the global single cell multi-omics market with the help of the key factors driving the market, the restraints, and the current growth opportunities that are going to shape the future trajectory of the market expansion. The report includes an in-depth examination of the key players and recent developments taking place in this market. Moreover, the report includes chapters on market dynamics (market drivers, opportunities, and challenges) and industry analysis as well.
The research study highlights the factors governing the industry attractiveness with the Porter’s Five Forces Analysis for a comprehensive understanding of the global single cell multi-omics market. Moreover, the study includes detailed product mapping, market estimation, and analysis of key trends in multiple geographical regions, growth of single cell multi-omics market in each region for different applications, and the key strategies and developments by the prominent single cell multi-omics manufacturers and service providers.
Market Segmentation
The market has been segmented into ‘type’, ‘workflow’, ‘product’, ‘applications’, ‘end users’, and ‘region’. The scope of this report is centered upon conducting a detailed study of the products and services allied with the single cell multi-omics market. In addition, the study also includes the exhaustive information on the unmet needs, perception on the new products, competitive landscape, market share of leading manufacturers, growth potential of each service, application, technology, end user, region, and company, as well as other vital information with respect to global single cell multi-omics market.
Based on region, the global single cell multi-omics market is segmented into North America, Europe, Asia-Pacific, Latin America, and Rest-of-the-World (RoW). North America is the leading contributor to the global single cell multi-omics market and was responsible for a 45.8% share of the global market values in 2018. However, the Asia-Pacific region is expected to grow at the fastest pace among all other regions with double digit CAGR, during the forecast period 2019-2025.
Key Companies in the Global Single Cell Multi-Omics Market
The key players who have been contributing significantly to the global single cell multi-omics market include 10x Genomics, Inc., 1CellBio, MissionBio, NanoString Technologies, Inc., Fluidigm Corporation, Fluxion Biosciences, Bio-Rad Laboratories, Inc., Celsee, Inc., BGI Genomics Co. Ltd. GE LifeSciences, Illumina, Inc., and Takara Bio, QIAGEN N.V., among others.
EXECUTIVE SUMMARY
1 SINGLE CELL MULTI-OMICS MARKET: GLOBAL PERSPECTIVE
1.1 Introduction
1.1.1 Single Cell Sequencing Data and Bioinformatics Analysis
1.1.1.1 Analysis of Single Cell Genomic Data
1.1.1.2 Analysis of Single Cell Transcriptome Sequencing
1.1.1.3 Analysis of Single Cell Methylome Sequencing
1.1.1.4 Analysis of Singe Cell Epigenome Sequencing
1.2 Global Single Cell Multi-Omics Market Size, 2018-2025
1.3 Single Cell Multi-Omics Technologies and Advancement in Recent Past, 2010-2017
1.3.1 Advances in Single Cell Multi-Omics Sequencing Technologies:
1.3.1.1 Single Cell RNA Sequencing Methods
1.3.1.2 Single Cell DNA Sequencing Methods
1.3.1.3 Single Cell Epigenetic Sequencing Methods
1.3.2 Technological Development in Single Cell Sequencing
1.3.2.1 Advancements in Imaging Techniques for Single Cell Sequencing
1.3.2.2 Advancements in Single Cell Collection and Analysis System
1.4 Single Cell Trends and Key Innovators
1.4.1 Recent Trends in Single Cell
1.4.1.1 Use of CRISPR in Single Cell Genomics
1.4.1.2 Application of Single Cell Genomics in Plants
1.4.1.3 Application of Single Cell Genomics in Animals
1.4.1.4 Single Cell Multi-Omics
1.4.1.5 Computational Analysis in Single Cell Genomics
1.4.2 Key innovators in Single Cell Multi-Omics
1.5 Single Cell Multi-Omics Research Funding
1.6 Single Cell Multi-Omics Publications and its Regional Distribution
1.7 Role of Regulatory Bodies and Consortium in Single Cell Multi-Omics Market
1.8 Key Companies in Single Cell Multi-Omics Market and their Contributions
2 MARKET DYNAMICS
2.1 Overview
2.2 Impact Analysis
2.3 Market Drivers
2.3.1 Need for Non-Invasive Diagnosis
2.3.2 Advancements in Single Cell Sequencing Techniques
2.3.3 Increase in Adoption of Personalized Medicine
2.4 Market Restraints
2.4.1 Lack of Tools for Computational Analysis
2.4.2 High Capital Requirement
2.4.3 Lack of Infrastructure and Expertise
2.5 Opportunities
2.5.1 Expansion into Emerging Markets
2.5.2 Expansion into New Research Application
2.5.3 Expansion of the Product Portfolio
3 ADDRESSABLE MARKET SIZE AND POTENTIAL GROWTH
3.1 North America
3.2 Europe
3.3 Asia-Pacific
3.4 Latin America
3.5 Rest-of-the-World
4 INDUSTRY INSIGHTS
4.1 Key Strategies and Developments
4.1.1 Product Launch
4.1.2 Synergistic Activities
4.1.3 Mergers and Acquisitions
4.1.4 Funding
4.1.5 Legal Requirements and Regulations
4.1.5.1 Legal Requirements and Framework in U.S.
4.1.5.2 Legal Requirements and Regulations in Europe
4.1.5.3 Legal Requirements and Framework in Asia-Pacific
4.1.5.3.1 China
4.1.5.3.2 Japan
4.2 Industry Attractiveness
4.2.1 Bargaining Power of Suppliers
4.2.2 Bargaining Power of Buyers
4.2.3 Threat of New Entrants
4.2.4 Threat of Substitute Products
4.2.5 Intensity of Competitive Rivalry
5 GLOBAL SINGLE CELL MULTI-OMICS MARKET BY TYPE, 2018-2025 ($MILLIONS)
5.1 Single Cell Genomics
5.1.1 Overview
5.1.2 Market Size and Forecast
5.1.3 Key Developments
5.1.4 Competitive Insights
5.2 Single Cell Transcriptomics and Proteomics
5.2.1 Overview
5.2.2 Market Size and Forecast
5.2.3 Key Developments
5.2.4 Competitive Insights
5.3 Single Cell Metabolomics
5.3.1 Overview
5.3.2 Market Size and Forecast
5.3.3 Key Developments
5.3.4 Competitive Insights
6 GLOBAL SINGLE CELL MULTI-OMICS MARKET (BY PRODUCT), 2018-2025 ($MILLION)
6.1 Instruments
6.1.1 Flow Cytometers/FACS Instruments
6.1.2 Next-Generation Sequencing Systems
6.1.3 Polymerase Chain Reaction
6.1.4 Microscopes
6.1.5 Microarray Systems
6.1.6 Spectrophotometers
6.1.7 Microplate Readers
6.1.8 Cell Counters
6.1.9 Cell sorters
6.1.10 Others
6.2 Consumables
6.2.1 Beads
6.2.2 Microplates
6.2.3 Assay kits
6.2.4 Reagents
6.2.5 Others
7 GLOBAL SINGLE CELL MULTI-OMICS MARKET BY WORKFLOW, 2018-2025 ($MILLIONS)
7.1 Single Cell Isolation
7.1.1 Flow Cytometry/FACS
7.1.2 Manual Cell Picking
7.1.3 Magnetic-activated Cell Sorting
7.1.4 Laser Microdissection
7.1.5 Random seeding/ Limiting Dilution
7.1.6 Microfluidics
7.1.7 Others
7.2 Single Cell Preparation
7.2.1 Microfluidics
7.2.2 Whole genome amplification
7.2.3 Single Cell RNA-seq
7.2.4 Others
7.3 Single Cell Analysis
7.3.1 Polymerase Chain Reaction
7.3.2 Next Generation Sequencing
7.3.3 Microarray
7.3.4 Multiple Displacement Amplification
7.3.5 Multiple Annealing and Looping-based Amplification Cycles (MALBAC)
7.3.6 Flow Cytometry
7.3.7 Mass Spectrometry
7.3.8 Microscopy (Fluorescence, Phase and Bright Field)
7.3.9 Microfluidics
7.3.10 Others
7.3.10.1 In-Vitro Transcription
7.3.10.2 phi29 DNA Polymerase
7.3.10.2.1 MA
7.3.10.2.2 TTA
8 GLOBAL SINGLE CELL MULTI-OMICS MARKET BY END USER, 2018-2025 ($MILLIONS)
8.1 Overview
8.2 Research and Academic Laboratories
8.3 Biopharmaceutical and Biotech Companies
8.4 Others (Hospitals, Clinics, and Diagnostic Labs)
9 GLOBAL SINGLE CELL MULTI-OMICS MARKET (BY REGION)
9.1 Overview
9.2 North America
9.2.1 U.S.
9.2.2 Canada
9.3 Europe
9.3.1 Germany
9.3.2 France
9.3.3 U.K.
9.3.4 Italy
9.3.5 Spain
9.3.6 Rest-of-Europe
9.4 Asia-Pacific
9.4.1 Japan
9.4.2 Singapore
9.4.3 India
9.4.4 China
9.4.5 South Korea
9.4.6 Australia
9.4.7 Rest-of-APAC
9.5 Latin America
9.5.1 Mexico
9.5.2 Brazil
9.5.3 Rest-of-Latin America
9.6 Rest-of-the-World
10 GLOBAL SINGLE CELL MULTI-OMICS MARKET (BY APPLICATION), $MILLION, 2018-2025
10.1 Oncology
10.2 Immunology
10.3 Neurology
10.4 Microbiology
10.5 Stem Cell
10.6 Cell Biology
10.7 Others
11 COMPETITIVE LANDSCAPE
11.1 Growth Share Analysis
11.2 Market Share Analysis
11.3 Competitor Value Chain Analysis
11.4 Competitor Supply Chain Analysis
12 COMPANY PROFILES
12.1 Overview
12.2 1CellBio
12.2.1 Company Overview
12.2.2 Role of 1CellBio in the Global Single Cell Multi-Omics Market
12.2.3 SWOT Analysis
12.3 10x Genomics Inc.
12.3.1 Company Overview
12.3.2 Role of 10x Genomics Inc. in the Global Single Cell Multi-Omics Market
12.3.3 SWOT Analysis
12.4 Becton, Dickinson and Company
12.4.1 Company Overview
12.4.2 Role of Becton, Dickinson and Company in the Global Single Cell Multi-Omics Market
12.4.3 Key Insights about Financial Health of the Company
12.4.4 SWOT Analysis
12.5 Bio-Rad Laboratories, Inc.
12.5.1 Company Overview
12.5.2 Role of Bio-Rad Laboratories, Inc. in the Global Single Cell Multi-Omics Market
12.5.3 Key Insights about Financial Health Company
12.5.4 SWOT Analysis
12.6 BGI Genomics Co. Ltd.
12.6.1 Company Overview
12.6.2 Role of BGI in Single-Cell Multi-Omics Market
12.6.3 SWOT Analysis
12.7 Celsee Inc.
12.7.1 Company Overview
12.7.2 Role of Celsee Inc. in the Global Single Cell Multi-Omics Market
12.7.3 SWOT Analysis
12.8 Fluidigm Corporation
12.8.1 Company Overview
12.8.2 Role of Fluidigm Corporation in the Global Single Cell Multi-Omics Market
12.8.3 Key Insights about Financial Health of the Company
12.8.4 SWOT ANALYSIS
12.9 Fluxion Biosciences
12.9.1 Company Overview
12.9.2 Role of Fluxion Biosciences in the Global Single Cell Multi-Omics Market
12.9.3 SWOT Analysis
12.10 GE
12.10.1 Company Overview
12.10.2 Role of GE Healthcare in the Global Single Cell Multi-Omics Market
12.10.3 Key Insights about Financial Health Company
12.10.4 SWOT Analysis
12.11 Mission Bio
12.11.1 Company Overview
12.11.2 Role of Mission Bio in the Single Cell Multi-Omics Market
12.11.3 SWOT Analysis
12.12 NanoString Technologies, Inc.
12.12.1 Company Overview
12.12.2 Role of NanoString Technologies, Inc. in the Global Single Cell Multi-Omics Market
12.12.3 Key Insights about Financial Health of the Company
12.12.4 SWOT Analysis
12.13 Illumina, Inc.
12.13.1 Company Overview
12.13.2 Role Illumina, Inc. in the Global Single Cell Multi-Omics Market
12.13.3 Key Insights about Financial Health Company
12.13.4 SWOT Analysis
12.14 PerkinElmer, Inc.
12.14.1 Company Overview
12.14.2 Role of PerkinElmer, Inc. in the Global Single Cell Multi-Omics Market
12.14.3 Key Insights about Financial Health of Company
12.14.4 SWOT Analysis
12.15 QIAGEN N.V.
12.15.1 Company Overview
12.15.2 Role of QIAGEN N.V. in the Global Single Cell Multi-Omics Market
12.15.3 Key Insights about Financial Health of Company
12.15.4 SWOT Analysis
12.16 Takara Bio, Inc.
12.16.1 Company Overview
12.16.2 Role of Takara Bio, Inc. in the Global Single Cell Multi-Omics Market
12.16.3 Key Insights about Financial Health of Company
12.16.4 SWOT Analysis
13 RESEARCH SCOPE AND METHODOLOGY
13.1 Research Scope
13.2 Global Single Cell Multi-Omics Market: Research Methodology
1 SINGLE CELL MULTI-OMICS MARKET: GLOBAL PERSPECTIVE
1.1 Introduction
1.1.1 Single Cell Sequencing Data and Bioinformatics Analysis
1.1.1.1 Analysis of Single Cell Genomic Data
1.1.1.2 Analysis of Single Cell Transcriptome Sequencing
1.1.1.3 Analysis of Single Cell Methylome Sequencing
1.1.1.4 Analysis of Singe Cell Epigenome Sequencing
1.2 Global Single Cell Multi-Omics Market Size, 2018-2025
1.3 Single Cell Multi-Omics Technologies and Advancement in Recent Past, 2010-2017
1.3.1 Advances in Single Cell Multi-Omics Sequencing Technologies:
1.3.1.1 Single Cell RNA Sequencing Methods
1.3.1.2 Single Cell DNA Sequencing Methods
1.3.1.3 Single Cell Epigenetic Sequencing Methods
1.3.2 Technological Development in Single Cell Sequencing
1.3.2.1 Advancements in Imaging Techniques for Single Cell Sequencing
1.3.2.2 Advancements in Single Cell Collection and Analysis System
1.4 Single Cell Trends and Key Innovators
1.4.1 Recent Trends in Single Cell
1.4.1.1 Use of CRISPR in Single Cell Genomics
1.4.1.2 Application of Single Cell Genomics in Plants
1.4.1.3 Application of Single Cell Genomics in Animals
1.4.1.4 Single Cell Multi-Omics
1.4.1.5 Computational Analysis in Single Cell Genomics
1.4.2 Key innovators in Single Cell Multi-Omics
1.5 Single Cell Multi-Omics Research Funding
1.6 Single Cell Multi-Omics Publications and its Regional Distribution
1.7 Role of Regulatory Bodies and Consortium in Single Cell Multi-Omics Market
1.8 Key Companies in Single Cell Multi-Omics Market and their Contributions
2 MARKET DYNAMICS
2.1 Overview
2.2 Impact Analysis
2.3 Market Drivers
2.3.1 Need for Non-Invasive Diagnosis
2.3.2 Advancements in Single Cell Sequencing Techniques
2.3.3 Increase in Adoption of Personalized Medicine
2.4 Market Restraints
2.4.1 Lack of Tools for Computational Analysis
2.4.2 High Capital Requirement
2.4.3 Lack of Infrastructure and Expertise
2.5 Opportunities
2.5.1 Expansion into Emerging Markets
2.5.2 Expansion into New Research Application
2.5.3 Expansion of the Product Portfolio
3 ADDRESSABLE MARKET SIZE AND POTENTIAL GROWTH
3.1 North America
3.2 Europe
3.3 Asia-Pacific
3.4 Latin America
3.5 Rest-of-the-World
4 INDUSTRY INSIGHTS
4.1 Key Strategies and Developments
4.1.1 Product Launch
4.1.2 Synergistic Activities
4.1.3 Mergers and Acquisitions
4.1.4 Funding
4.1.5 Legal Requirements and Regulations
4.1.5.1 Legal Requirements and Framework in U.S.
4.1.5.2 Legal Requirements and Regulations in Europe
4.1.5.3 Legal Requirements and Framework in Asia-Pacific
4.1.5.3.1 China
4.1.5.3.2 Japan
4.2 Industry Attractiveness
4.2.1 Bargaining Power of Suppliers
4.2.2 Bargaining Power of Buyers
4.2.3 Threat of New Entrants
4.2.4 Threat of Substitute Products
4.2.5 Intensity of Competitive Rivalry
5 GLOBAL SINGLE CELL MULTI-OMICS MARKET BY TYPE, 2018-2025 ($MILLIONS)
5.1 Single Cell Genomics
5.1.1 Overview
5.1.2 Market Size and Forecast
5.1.3 Key Developments
5.1.4 Competitive Insights
5.2 Single Cell Transcriptomics and Proteomics
5.2.1 Overview
5.2.2 Market Size and Forecast
5.2.3 Key Developments
5.2.4 Competitive Insights
5.3 Single Cell Metabolomics
5.3.1 Overview
5.3.2 Market Size and Forecast
5.3.3 Key Developments
5.3.4 Competitive Insights
6 GLOBAL SINGLE CELL MULTI-OMICS MARKET (BY PRODUCT), 2018-2025 ($MILLION)
6.1 Instruments
6.1.1 Flow Cytometers/FACS Instruments
6.1.2 Next-Generation Sequencing Systems
6.1.3 Polymerase Chain Reaction
6.1.4 Microscopes
6.1.5 Microarray Systems
6.1.6 Spectrophotometers
6.1.7 Microplate Readers
6.1.8 Cell Counters
6.1.9 Cell sorters
6.1.10 Others
6.2 Consumables
6.2.1 Beads
6.2.2 Microplates
6.2.3 Assay kits
6.2.4 Reagents
6.2.5 Others
7 GLOBAL SINGLE CELL MULTI-OMICS MARKET BY WORKFLOW, 2018-2025 ($MILLIONS)
7.1 Single Cell Isolation
7.1.1 Flow Cytometry/FACS
7.1.2 Manual Cell Picking
7.1.3 Magnetic-activated Cell Sorting
7.1.4 Laser Microdissection
7.1.5 Random seeding/ Limiting Dilution
7.1.6 Microfluidics
7.1.7 Others
7.2 Single Cell Preparation
7.2.1 Microfluidics
7.2.2 Whole genome amplification
7.2.3 Single Cell RNA-seq
7.2.4 Others
7.3 Single Cell Analysis
7.3.1 Polymerase Chain Reaction
7.3.2 Next Generation Sequencing
7.3.3 Microarray
7.3.4 Multiple Displacement Amplification
7.3.5 Multiple Annealing and Looping-based Amplification Cycles (MALBAC)
7.3.6 Flow Cytometry
7.3.7 Mass Spectrometry
7.3.8 Microscopy (Fluorescence, Phase and Bright Field)
7.3.9 Microfluidics
7.3.10 Others
7.3.10.1 In-Vitro Transcription
7.3.10.2 phi29 DNA Polymerase
7.3.10.2.1 MA
7.3.10.2.2 TTA
8 GLOBAL SINGLE CELL MULTI-OMICS MARKET BY END USER, 2018-2025 ($MILLIONS)
8.1 Overview
8.2 Research and Academic Laboratories
8.3 Biopharmaceutical and Biotech Companies
8.4 Others (Hospitals, Clinics, and Diagnostic Labs)
9 GLOBAL SINGLE CELL MULTI-OMICS MARKET (BY REGION)
9.1 Overview
9.2 North America
9.2.1 U.S.
9.2.2 Canada
9.3 Europe
9.3.1 Germany
9.3.2 France
9.3.3 U.K.
9.3.4 Italy
9.3.5 Spain
9.3.6 Rest-of-Europe
9.4 Asia-Pacific
9.4.1 Japan
9.4.2 Singapore
9.4.3 India
9.4.4 China
9.4.5 South Korea
9.4.6 Australia
9.4.7 Rest-of-APAC
9.5 Latin America
9.5.1 Mexico
9.5.2 Brazil
9.5.3 Rest-of-Latin America
9.6 Rest-of-the-World
10 GLOBAL SINGLE CELL MULTI-OMICS MARKET (BY APPLICATION), $MILLION, 2018-2025
10.1 Oncology
10.2 Immunology
10.3 Neurology
10.4 Microbiology
10.5 Stem Cell
10.6 Cell Biology
10.7 Others
11 COMPETITIVE LANDSCAPE
11.1 Growth Share Analysis
11.2 Market Share Analysis
11.3 Competitor Value Chain Analysis
11.4 Competitor Supply Chain Analysis
12 COMPANY PROFILES
12.1 Overview
12.2 1CellBio
12.2.1 Company Overview
12.2.2 Role of 1CellBio in the Global Single Cell Multi-Omics Market
12.2.3 SWOT Analysis
12.3 10x Genomics Inc.
12.3.1 Company Overview
12.3.2 Role of 10x Genomics Inc. in the Global Single Cell Multi-Omics Market
12.3.3 SWOT Analysis
12.4 Becton, Dickinson and Company
12.4.1 Company Overview
12.4.2 Role of Becton, Dickinson and Company in the Global Single Cell Multi-Omics Market
12.4.3 Key Insights about Financial Health of the Company
12.4.4 SWOT Analysis
12.5 Bio-Rad Laboratories, Inc.
12.5.1 Company Overview
12.5.2 Role of Bio-Rad Laboratories, Inc. in the Global Single Cell Multi-Omics Market
12.5.3 Key Insights about Financial Health Company
12.5.4 SWOT Analysis
12.6 BGI Genomics Co. Ltd.
12.6.1 Company Overview
12.6.2 Role of BGI in Single-Cell Multi-Omics Market
12.6.3 SWOT Analysis
12.7 Celsee Inc.
12.7.1 Company Overview
12.7.2 Role of Celsee Inc. in the Global Single Cell Multi-Omics Market
12.7.3 SWOT Analysis
12.8 Fluidigm Corporation
12.8.1 Company Overview
12.8.2 Role of Fluidigm Corporation in the Global Single Cell Multi-Omics Market
12.8.3 Key Insights about Financial Health of the Company
12.8.4 SWOT ANALYSIS
12.9 Fluxion Biosciences
12.9.1 Company Overview
12.9.2 Role of Fluxion Biosciences in the Global Single Cell Multi-Omics Market
12.9.3 SWOT Analysis
12.10 GE
12.10.1 Company Overview
12.10.2 Role of GE Healthcare in the Global Single Cell Multi-Omics Market
12.10.3 Key Insights about Financial Health Company
12.10.4 SWOT Analysis
12.11 Mission Bio
12.11.1 Company Overview
12.11.2 Role of Mission Bio in the Single Cell Multi-Omics Market
12.11.3 SWOT Analysis
12.12 NanoString Technologies, Inc.
12.12.1 Company Overview
12.12.2 Role of NanoString Technologies, Inc. in the Global Single Cell Multi-Omics Market
12.12.3 Key Insights about Financial Health of the Company
12.12.4 SWOT Analysis
12.13 Illumina, Inc.
12.13.1 Company Overview
12.13.2 Role Illumina, Inc. in the Global Single Cell Multi-Omics Market
12.13.3 Key Insights about Financial Health Company
12.13.4 SWOT Analysis
12.14 PerkinElmer, Inc.
12.14.1 Company Overview
12.14.2 Role of PerkinElmer, Inc. in the Global Single Cell Multi-Omics Market
12.14.3 Key Insights about Financial Health of Company
12.14.4 SWOT Analysis
12.15 QIAGEN N.V.
12.15.1 Company Overview
12.15.2 Role of QIAGEN N.V. in the Global Single Cell Multi-Omics Market
12.15.3 Key Insights about Financial Health of Company
12.15.4 SWOT Analysis
12.16 Takara Bio, Inc.
12.16.1 Company Overview
12.16.2 Role of Takara Bio, Inc. in the Global Single Cell Multi-Omics Market
12.16.3 Key Insights about Financial Health of Company
12.16.4 SWOT Analysis
13 RESEARCH SCOPE AND METHODOLOGY
13.1 Research Scope
13.2 Global Single Cell Multi-Omics Market: Research Methodology
LIST OF TABLES
Table 1: Methods for Single Cell Multi-Omics
Table 1.1: Single Cell Multi-Omics Research Funding
Table 1.2: List of Publication of Single Cell Multi-Omics:
Table 1.3: List of Publication of Single Cell Multi-Omics at Regional Level:
Table 1.4: Regulatory Bodies and Consortiums of Single Cell Multi-Omics Market
Table 1.5: Major Contributions by Key Players in the Market
Table 2.1: Impact Analysis
Table 2.2: Impact Analysis: Market Restraints
Table 4.1: Classification of Directive Groups IVDs
Table 5.1: Key Developments in Single Cell Genomic Market
Table 5.2: Products offered for Single Cell Genomics
Table 5.3: Key Developments in Single Cell Transcriptomics and Proteomics Market
Table 5.4: Products offered for Single Cell Transcriptomics and Proteomics
Table 5.5: Developments in the Techniques for Single Cell Metabolomics
Table 5.6: Products offered for Single Cell Metabolomics
Table 7.1: Products for Fluorescence-activated Cell Sorting
Table 7.2: Products for Manual Cell Picking
Table 7.3: Products for Magnetic-activated Cell Sorting
Table 7.4: Products for Laser Microdissection
Table 7.5: Products for Random Seeding/ Limited Dilution
Table 7.6: Products for Microfluidics
Table 7.7: Others Products Available for Single Cell Isolation
Table 7.8: Products for Microfluidics
Table 7.9: Products for Whole Genome Amplification
Table 7.10: Products for Single Cell RNA-seq
Table 7.11: PCR Based Products for Single Cell Isolation
Table 7.12: NGS Based Products for Single Cell Isolation
Table 7.13: PCR Based Products for Single Cell Isolation
Table 7.14: Multiple Displacement Amplification Based Products for Single Cell Analysis
Table 7.15: Multiple Annealing and Looping-based Amplification Based Products for Single Cell Analysis
Table 7.16: Flow Cytometry Based Products for Single Cell Analysis
Table 7.17: Mass Spectrometry Based Products for Single Cell Analysis
Table 7.18: Advanced Techniques for Live Cell Imaging
Table 7.19: Mass Spectrometry Based Products for Single Cell Analysis
Table 7.20: Microfluidics Based Products for Single Cell Analysis
Table 7.21: In-Vitro Transcription Based Products for Single Cell Analysis
Table 7.22: phi29 DNA Polymerase Based Products for Single Cell Analysis
Table 1: Methods for Single Cell Multi-Omics
Table 1.1: Single Cell Multi-Omics Research Funding
Table 1.2: List of Publication of Single Cell Multi-Omics:
Table 1.3: List of Publication of Single Cell Multi-Omics at Regional Level:
Table 1.4: Regulatory Bodies and Consortiums of Single Cell Multi-Omics Market
Table 1.5: Major Contributions by Key Players in the Market
Table 2.1: Impact Analysis
Table 2.2: Impact Analysis: Market Restraints
Table 4.1: Classification of Directive Groups IVDs
Table 5.1: Key Developments in Single Cell Genomic Market
Table 5.2: Products offered for Single Cell Genomics
Table 5.3: Key Developments in Single Cell Transcriptomics and Proteomics Market
Table 5.4: Products offered for Single Cell Transcriptomics and Proteomics
Table 5.5: Developments in the Techniques for Single Cell Metabolomics
Table 5.6: Products offered for Single Cell Metabolomics
Table 7.1: Products for Fluorescence-activated Cell Sorting
Table 7.2: Products for Manual Cell Picking
Table 7.3: Products for Magnetic-activated Cell Sorting
Table 7.4: Products for Laser Microdissection
Table 7.5: Products for Random Seeding/ Limited Dilution
Table 7.6: Products for Microfluidics
Table 7.7: Others Products Available for Single Cell Isolation
Table 7.8: Products for Microfluidics
Table 7.9: Products for Whole Genome Amplification
Table 7.10: Products for Single Cell RNA-seq
Table 7.11: PCR Based Products for Single Cell Isolation
Table 7.12: NGS Based Products for Single Cell Isolation
Table 7.13: PCR Based Products for Single Cell Isolation
Table 7.14: Multiple Displacement Amplification Based Products for Single Cell Analysis
Table 7.15: Multiple Annealing and Looping-based Amplification Based Products for Single Cell Analysis
Table 7.16: Flow Cytometry Based Products for Single Cell Analysis
Table 7.17: Mass Spectrometry Based Products for Single Cell Analysis
Table 7.18: Advanced Techniques for Live Cell Imaging
Table 7.19: Mass Spectrometry Based Products for Single Cell Analysis
Table 7.20: Microfluidics Based Products for Single Cell Analysis
Table 7.21: In-Vitro Transcription Based Products for Single Cell Analysis
Table 7.22: phi29 DNA Polymerase Based Products for Single Cell Analysis
LIST OF FIGURES
Figure 1: Drivers and Restraints of Next-Generation Sequencing Market
Figure 2: Key Strategies Incorporated by Stakeholders of NGS Market, to Sustain the Competition (from January 2016 to April 2019)
Figure 3: Global Single Cell Multi-Omics Market Snapshot
Figure 4: Dominating Segments of Global Single Cell Multi-Omics, 2018 and 2025
Figure 5: Global Single Cell Multi-Omics Market Share (By Product), 2018-2025
Figure 6: Global Single Cell Multi-Omics Market Share (By Technology), 2018-2025
Figure 7: Global Single Cell Multi-Omics Market Share (By Workflow), 2018-2025
Figure 8: Global Single Cell Multi-Omics Market Share (By End-User), 2018-2025
Figure 9: Global Single Cell Multi-Omics Market Share (By Application), 2018-2025
Figure 1.1: Single Cell Multi-Omics Approach
Figure 1.2: Evolution of Single Cell Multi-Omics Technology
Figure 1.3: Global Single Cell Multi-Omics Market Size, 2018-2025
Figure 1.4: Three Major Technological Development in Single Cell Sequencing
Figure 1.5: Traditional and Modern Approaches for Single Cell Isolation
Figure 2.1: Market Dynamics of Global Single Cell Multi-Omics Market
Figure 3.1: North America Single Cell Multi-Omics Addressable Market by 2025
Figure 3.2: Europe Single Cell Multi-Omics Addressable Market by 2025
Figure 3.3: Asia-pacific Single Cell Multi-Omics Addressable Market by 2025
Figure 3.4: Latin America Single Cell Multi-Omics Addressable Market by 2025
Figure 3.5: Rest of World Single Cell Multi-Omics Addressable Market by 2025
Figure 4.1: Share of Key Developments and Strategies, (January 2016 – April 2019)
Figure 4.2: Product Launches Share (by Companies), January 2016 – April 2019
Figure 4.3: Synergistic Activities Share (by Companies), January 2016 – April 2019
Figure 4.4: Acquisitions Share (by Companies), January 2016 – April 2019
Figure 4.5: Funding Share (by Companies), January 2016 – April 2019
Figure 4.6: Overall Industry Attractiveness, 2018 and 2025
Figure 4.7: Overall Impact of Bargaining Power of Suppliers
Figure 4.8: Overall Impact of Bargaining Power of Buyers
Figure 4.9: Overall Impact of Threat of New Entrants
Figure 4.10: Overall Impact of Threat of Substitute Products
Figure 4.11: Overall Impact of Intensity of Competitive Rivalry
Figure 5.1: Types of Omics Platforms
Figure 5.2: Global Single Cell Genomics Market, 2018-2025
Figure 5.3: Global Single Cell Transcriptomics and Proteomics Market, 2018-2025
Figure 5.4: Global Single Cell Metabolomics Market, 2018-2025
Figure 6.1: Global Single Cell Multi-Omics Market (by Product Type)
Figure 6.2: Global Single Cell Multi-Omics (by Product Type), 2018 and 2025
Figure 6.3: Global Single Cell Multi-Omics Instruments Market, 2018-2025
Figure 6.4: Global Single Cell Multi-Omics FACS Market, 2018-2025
Figure 6.5: Global Single Cell Multi-Omics NGS System Market, 2018-2025
Figure 6.6: Global Single Cell Multi-Omics PCR Market, 2018-2025
Figure 6.7: Global Single Cell Multi-Omics Microscopes Market, 2018-2025
Figure 6.8: Global Single Cell Multi-Omics Microarray Systems Market, 2018-2025
Figure 6.9: Global Single Cell Multi-Omics Spectrophotometers Market, 2018-2025
Figure 6 10: Global Single Cell Multi-Omics Microplate Readers Market, 2018-2025
Figure 6.11: Global Single Cell Multi-Omics Cell Counter Market, 2018-2025
Figure 6.12: Global Single Cell Multi-Omics Cell Sorters Market, 2018-2025
Figure 6.13: Global Single Cell Multi-Omics Others Market, 2018-2025
Figure 6.14: Global Single Cell Multi-Omics Consumables Market, 2018-2025
Figure 6.15: Global Single Cell Multi-Omics Beads Market, 2018-2025
Figure 6.16: Global Single Cell Multi-Omics Microplates Market, 2018-2025
Figure 6.17: Global Single Cell Multi-Omics Microplates Market, 2018-2025
Figure 6.18: Global Single Cell Multi-Omics Reagents Market, 2018-2025
Figure 6.19: Global Single Cell Multi-Omics Consumables Market (Others), 2018-2025
Figure 7.1: Single Cell Isolation Methods
Figure 7.2: Global Single Cell Isolation Market, 2018-2025
Figure 7.3: Global Single Cell Flow Cytometry/FACS Market, 2018-2025
Figure 7.4: Global Single Cell Manual Cell Picking Market, 2018-2025
Figure 7.5: Global Single Cell Magnetic-activated Cell Sorting (MACS) Market, 2018-2025
Figure 7.6: Global Single Cell Laser Microdissection Market, 2018-2025
Figure 7.7: Global Single Cell Random Seeding/ Limiting Dilution Market, 2018-2025
Figure 7.8: Global Single Cell Microfluidics Market, 2018-2025
Figure 7.9: Global Single Cell Isolation Market (Others), 2018-2025
Figure 7.10: Sample Preparation Workflow
Figure 7.11: Methods for Single Cell Preparation
Figure 7.12: Global Single Cell Preparation Market, 2018-2025
Figure 7.13: Global Single Cell Preparation Microfluidics Market, 2018-2025
Figure 7.14: Global Single Cell Preparation Whole Genome Amplification Market, 2018-2025
Figure 7.15: Techniques for Whole Genome Amplification
Figure 7.16: Global Single Cell Preparation Single Cell RNA Sequencing, 2018-2025
Figure 7.17: Global Single Cell Preparation Market (Others), 2018-2025
Figure 7.18: Global Single Cell Analysis Market, 2018-2025
Figure 7.19: Global Single Cell Analysis Polymerase Chain Reaction Market, 2018-2025
Figure 7.20: Global Single Cell Analysis Next-Generation Sequencing Market, 2018-2025
Figure 7.21: Global Single Cell Analysis Microarray Market, 2018-2025
Figure 7.22: Global Single Cell Analysis Multiple Displacement Amplification Market, 2018-2025
Figure 7.23: Global Single Cell Analysis Multiple Annealing and Looping-based Amplification, 2018-2025
Figure 7.24: Global Single Cell Flow Cytometry Market, 2018-2025
Figure 7.25: Global Single Cell Analysis Mass Spectrometry Market, 2018-2025
Figure 7.26: Global Single Cell Analysis Microscopy Market, 2018-2025
Figure 7.27: Global Single Cell Microfluidics Market, 2018-2025
Figure 7.28: Global Single Cell Analysis Market (Others), 2018-2025
Figure 8.1: Global Single Cell Multi-Omics Market, By Research and Academia, 2018-2025
Figure 8.2: Global Single Cell Multi-Omics Market, By Biopharmaceutical and Biotech Companies, 2018-2025
Figure 8.3: Global Single Cell Multi-Omics Market, By Hospitals, Clinics and Diagnostic Labs (Others), 2018-2025
Figure 9.1: Global Single Cell Multi-Omics Market (by Region), 2018 and 2025
Figure 9.2: Global Single Cell Multi-Omics Market (by Region), 2018-2025
Figure 9.3: Global Single Cell Multi-Omics Market Share (by Region), 2018
Figure 9.4: Global Single cell multi-omics Market Share (by Region), 2025
Figure 9.5: North America Global Single Cell Multi-Omics Market, 2018-2025
Figure 9.6: North America: Market Dynamics
Figure 9.7: North America Single Cell Multi-Omics Market (By Country), 2018-2025
Figure 9.8: The U.S. Single Cell Multi-Omics Market, 2018-2025
Figure 9.9: Canada Single Cell Multi-Omics Market, 2018-2025
Figure 9.10: Europe Single Cell Multi-Omics Market, 2018-2025
Figure 9.11: Europe: Market Dynamics
Figure 9.12: Europe Global Single Cell Multi-Omics Market (by Country), 2018-2025
Figure 9.13: Germany Single Cell Multi-Omics Market, 2018-2025
Figure 9.14: France Single Cell Multi-Omics Market, 2018-2025
Figure 9.15: The U.K. Single Cell Multi-Omics Market, 2018-2025
Figure 9.16: Italy Single Cell Multi-Omics Market, 2018-2025
Figure 9 17: Spain Single Cell Multi-Omics Market, 2018-2025
Figure 9.18: Rest-of-Europe Single Cell Multi-Omics Market, 2018-2025
Figure 9.19: Asia-Pacific Single Cell Multi-Omics Market, 2018-2025
Figure 9.20: APAC: Market Dynamics
Figure 9.21: APAC Single Cell Multi-Omics Market (by Country), 2018-2025
Figure 9.22: Japan Single Cell Multi-Omics Market, 2018-2025
Figure 9.23: Singapore Single Cell Multi-Omics Market, 2018-2025
Figure 9.24: India Single Cell Multi-Omics Market, 2018-2025
Figure 9.25: China Single Cell Multi-Omics Market, 2018-2025
Figure 9.26: South Korea Single Cell Multi-Omics Market, 2018-2025
Figure 9.27: Australia Single Cell Multi-Omics Market, 2018-2025
Figure 9.28: RoAPAC Single Cell Multi-Omics Market, 2018-2025
Figure 9.29: Latin America Single Cell Multi-Omics Market, 2018-2025
Figure 9.30: Latin America: Market Dynamics
Figure 9.31: Latin America Single Cell Multi-Omics Market (by Country), 2018-2025
Figure 9.32: Mexico Single Cell Multi-Omics Market, 2018-2025
Figure 9.33: Brazil Single Cell Multi-Omics Market, 2018-2025
Figure 9.34: Rest-of-Latin America Single Cell Multi-Omics Market, 2018-2025
Figure 9.35: RoW Single Cell Multi-Omics Market, 2018-2025
Figure 10.1: Applications of Single-Cell Multi-Omics
Figure 10.2: Global Single Cell Multi-Omics Market for Oncology Application (2018-2025)
Figure 10.3: Method for single cell RNA sequencing methods
Figure 10.4: Global Single Cell Multi-Omics Market for Immunology Application (2018-2025)
Figure 10.5: Global Single Cell Multi-Omics Market for Neurology Application (2018-2025)
Figure 10.6: Global Single Cell Multi-Omics Market for Microbiology Application (2018-2025)
Figure 10.7: Global Single Cell Multi-Omics Stem Cell Market (2018-2025)
Figure 10.8: Global Single Cell Multi-Omics Cell Biology Market (2018-2025)
Figure 10.9: Global Single Cell Multi-Omics Other Application Market (2018-2025)
Figure 11.1: Growth Share Matrix for Global Single Cell Multi-Omics Market (by Companies), 2018
Figure 11.2: Market Share Analysis for the Global Single Cell Multi-Omics Market, 2018
Figure 11.3: Components of Value Chain
Figure 11.4: Value Chain Analysis of Medical Device Industry
Figure 11.5: Supply Chain Analysis of a Medical Device Industry
Figure 12.1: Shares of Key Company Profiles
Figure 12.2: 1CellBio: SWOT Analysis
Figure 12.3: 10x Genomics Inc.: SWOT Analysis
Figure 12.4: Becton, Dickinson and Company: Overall Financials, 2016-2018
Figure 12.5: Becton, Dickinson and Company: Revenue (by Business Segment), 2015-2018
Figure 12.6: Becton, Dickinson and Company: Revenue (by Region), 2015-2018
Figure 12.7: Becton, Dickinson and Company: R&D Expenditure, 2016-2018
Figure 12.8: Becton, Dickinson and Company: SWOT Analysis
Figure 12.9: Bio-Rad Laboratories, Inc.: Overall Financials, (2016-2018)
Figure 12.10: Bio-Rad Laboratories, Inc.: Revenue (by Business Segment), 2016-2018
Figure 12.11: Bio-Rad Laboratories, Inc.: Revenue (by Region), 2016-2018
Figure 12.12: Bio-Rad Laboratories, Inc., R&D Expenditure, 2016-2018
Figure 12.13: Bio-Rad Laboratories, Inc.: SWOT Analysis
Figure 12.14: BGI: SWOT Analysis
Figure 12.15: Celsee Inc.: SWOT Analysis
Figure 12.16: Fluidigm Corporation: Overall Financials, 2016-2018
Figure 12.17: Fluidigm Corporation: Revenue (by Business Segment), 2016-2018
Figure 12.18: Fluidigm Corporation: Revenue (by Region), 2016-2018
Figure 12.19: Fluidigm Corporation: R&D Expenditure, 2016-2018
Figure 12.20: Fluidigm Corporation: SWOT Analysis
Figure 12.21: Fluxion Biosciences: SWOT Analysis
Figure 12.22: GE: Revenue (by Business Segment), 2015-2018
Figure 12.23: GE: Revenue (Healthcare), 2016-2018
Figure 12.24: GE Healthcare: Revenue (by Business Segment), 2015-2018
Figure 12.25: GE: R&D Expenditure, 2016-2018
Figure 12.26: GE: R&D Expenditure (By Segment), 2015-2018
Figure 12.27: GE: Overall Financials, (2016-2018)
Figure 12.28: GE: Revenue (by Business Segment), 2016-2018
Figure 12.29: GE: Revenue (Healthcare), 2016-2018
Figure 12.30: GE Healthcare: Revenue (by Business Segment), 2016-2018
Figure 12.31: GE: R&D Expenditure, 2016-2018
Figure 12.32: GE: R&D Expenditure (By Segment), 2016-2018
Figure 12.33: GE: SWOT Analysis
Figure 12.34: Mission Bio: SWOT Analysis
Figure 12.35: NanoString Technologies, Inc.: Overall Financials, (2016-2018)
Figure 12.36: NanoString Technologies, Inc.: Revenue (by Business Segment), 2016-2018
Figure 12.37: NanoString Technologies, Inc.: Revenue (by Region), 2016-2018
Figure 12.38: NanoString Technologies, Inc.: R&D Expenditure, 2016-2018
Figure 12.39: NanoString Technologies, Inc.: R&D Expenditure (By Functional Area), 2016-2018
Figure 12.40: NanoString Technologies: SWOT Analysis
Figure 12.41: Illumina Inc.: Overall Financials, (2016-2018)
Figure 12.42: Illumina, Inc.: Revenue (by Business Segment), 2016-2018
Figure 12.43: Illumina, Inc.: Revenue (by Region), 2016-2018
Figure 12.44: Illumina, Inc., R&D Expenditure, 2016-2018
Figure 12.45: Illumina, Inc. SWOT Analysis
Figure 12.46: Perkin Elmer, Inc.: Overall Financials, (2016-2018)
Figure 12.47: Perkin Elmer, Inc.: Revenue (by Business Segment), 2016-2018
Figure 12.48: Perkin Elmer, Inc.: Revenue (by Region), 2016-2018
Figure 12.49: PerkinElmer, Inc., Inc.: R&D Expenditure, 2016-2018
Figure 12.50: PerkinElmer, Inc.: SWOT Analysis
Figure 12.51: QIAGEN N.V..: Overall Financials, (2015-2017)
Figure 12.52: QIAGEN N.V.: Revenue (by Business Segment), 2015-2017
Figure 12.53: QIAGEN N.V.: Revenue (by Region), 2015-2017
Figure 12.54: QIAGEN N.V.: R&D Expenditure, 2015-2017
Figure 12.55: QIAGEN N.V.: SWOT Analysis
Figure 12.56: Takara Bio Inc.: Overall Financials, (2016-2018)
Figure 12.57: Takara Bio, Inc.: Revenue (by Business Segment), 2016-2018
Figure 12.58: Takara Bio, Inc.: Revenue (by Region), 2017
Figure 12.59: Takara Bio, Inc., R&D Expenditure, 2015-2017
Figure 12.60: Takara Bio Inc.: SWOT Analysis
Figure 13.1: Global Single Cell Multi-Omics Market Segmentation
Figure 13.2: Global Single Cell Multi-Omics Market Research Methodology
Figure 13.3: Primary Research
Figure 13.4: Secondary Research
Figure 13.5: Data Triangulation
Figure 13.6: Bottom-up Approach (Segment-wise Analysis)
Figure 13.7: Top-down Approach (Segment-wise Analysis)
Figure 13.8: Assumptions and Limitations
Figure 13.9: Considered Factors for Data Prediction and Modeling
Figure 1: Drivers and Restraints of Next-Generation Sequencing Market
Figure 2: Key Strategies Incorporated by Stakeholders of NGS Market, to Sustain the Competition (from January 2016 to April 2019)
Figure 3: Global Single Cell Multi-Omics Market Snapshot
Figure 4: Dominating Segments of Global Single Cell Multi-Omics, 2018 and 2025
Figure 5: Global Single Cell Multi-Omics Market Share (By Product), 2018-2025
Figure 6: Global Single Cell Multi-Omics Market Share (By Technology), 2018-2025
Figure 7: Global Single Cell Multi-Omics Market Share (By Workflow), 2018-2025
Figure 8: Global Single Cell Multi-Omics Market Share (By End-User), 2018-2025
Figure 9: Global Single Cell Multi-Omics Market Share (By Application), 2018-2025
Figure 1.1: Single Cell Multi-Omics Approach
Figure 1.2: Evolution of Single Cell Multi-Omics Technology
Figure 1.3: Global Single Cell Multi-Omics Market Size, 2018-2025
Figure 1.4: Three Major Technological Development in Single Cell Sequencing
Figure 1.5: Traditional and Modern Approaches for Single Cell Isolation
Figure 2.1: Market Dynamics of Global Single Cell Multi-Omics Market
Figure 3.1: North America Single Cell Multi-Omics Addressable Market by 2025
Figure 3.2: Europe Single Cell Multi-Omics Addressable Market by 2025
Figure 3.3: Asia-pacific Single Cell Multi-Omics Addressable Market by 2025
Figure 3.4: Latin America Single Cell Multi-Omics Addressable Market by 2025
Figure 3.5: Rest of World Single Cell Multi-Omics Addressable Market by 2025
Figure 4.1: Share of Key Developments and Strategies, (January 2016 – April 2019)
Figure 4.2: Product Launches Share (by Companies), January 2016 – April 2019
Figure 4.3: Synergistic Activities Share (by Companies), January 2016 – April 2019
Figure 4.4: Acquisitions Share (by Companies), January 2016 – April 2019
Figure 4.5: Funding Share (by Companies), January 2016 – April 2019
Figure 4.6: Overall Industry Attractiveness, 2018 and 2025
Figure 4.7: Overall Impact of Bargaining Power of Suppliers
Figure 4.8: Overall Impact of Bargaining Power of Buyers
Figure 4.9: Overall Impact of Threat of New Entrants
Figure 4.10: Overall Impact of Threat of Substitute Products
Figure 4.11: Overall Impact of Intensity of Competitive Rivalry
Figure 5.1: Types of Omics Platforms
Figure 5.2: Global Single Cell Genomics Market, 2018-2025
Figure 5.3: Global Single Cell Transcriptomics and Proteomics Market, 2018-2025
Figure 5.4: Global Single Cell Metabolomics Market, 2018-2025
Figure 6.1: Global Single Cell Multi-Omics Market (by Product Type)
Figure 6.2: Global Single Cell Multi-Omics (by Product Type), 2018 and 2025
Figure 6.3: Global Single Cell Multi-Omics Instruments Market, 2018-2025
Figure 6.4: Global Single Cell Multi-Omics FACS Market, 2018-2025
Figure 6.5: Global Single Cell Multi-Omics NGS System Market, 2018-2025
Figure 6.6: Global Single Cell Multi-Omics PCR Market, 2018-2025
Figure 6.7: Global Single Cell Multi-Omics Microscopes Market, 2018-2025
Figure 6.8: Global Single Cell Multi-Omics Microarray Systems Market, 2018-2025
Figure 6.9: Global Single Cell Multi-Omics Spectrophotometers Market, 2018-2025
Figure 6 10: Global Single Cell Multi-Omics Microplate Readers Market, 2018-2025
Figure 6.11: Global Single Cell Multi-Omics Cell Counter Market, 2018-2025
Figure 6.12: Global Single Cell Multi-Omics Cell Sorters Market, 2018-2025
Figure 6.13: Global Single Cell Multi-Omics Others Market, 2018-2025
Figure 6.14: Global Single Cell Multi-Omics Consumables Market, 2018-2025
Figure 6.15: Global Single Cell Multi-Omics Beads Market, 2018-2025
Figure 6.16: Global Single Cell Multi-Omics Microplates Market, 2018-2025
Figure 6.17: Global Single Cell Multi-Omics Microplates Market, 2018-2025
Figure 6.18: Global Single Cell Multi-Omics Reagents Market, 2018-2025
Figure 6.19: Global Single Cell Multi-Omics Consumables Market (Others), 2018-2025
Figure 7.1: Single Cell Isolation Methods
Figure 7.2: Global Single Cell Isolation Market, 2018-2025
Figure 7.3: Global Single Cell Flow Cytometry/FACS Market, 2018-2025
Figure 7.4: Global Single Cell Manual Cell Picking Market, 2018-2025
Figure 7.5: Global Single Cell Magnetic-activated Cell Sorting (MACS) Market, 2018-2025
Figure 7.6: Global Single Cell Laser Microdissection Market, 2018-2025
Figure 7.7: Global Single Cell Random Seeding/ Limiting Dilution Market, 2018-2025
Figure 7.8: Global Single Cell Microfluidics Market, 2018-2025
Figure 7.9: Global Single Cell Isolation Market (Others), 2018-2025
Figure 7.10: Sample Preparation Workflow
Figure 7.11: Methods for Single Cell Preparation
Figure 7.12: Global Single Cell Preparation Market, 2018-2025
Figure 7.13: Global Single Cell Preparation Microfluidics Market, 2018-2025
Figure 7.14: Global Single Cell Preparation Whole Genome Amplification Market, 2018-2025
Figure 7.15: Techniques for Whole Genome Amplification
Figure 7.16: Global Single Cell Preparation Single Cell RNA Sequencing, 2018-2025
Figure 7.17: Global Single Cell Preparation Market (Others), 2018-2025
Figure 7.18: Global Single Cell Analysis Market, 2018-2025
Figure 7.19: Global Single Cell Analysis Polymerase Chain Reaction Market, 2018-2025
Figure 7.20: Global Single Cell Analysis Next-Generation Sequencing Market, 2018-2025
Figure 7.21: Global Single Cell Analysis Microarray Market, 2018-2025
Figure 7.22: Global Single Cell Analysis Multiple Displacement Amplification Market, 2018-2025
Figure 7.23: Global Single Cell Analysis Multiple Annealing and Looping-based Amplification, 2018-2025
Figure 7.24: Global Single Cell Flow Cytometry Market, 2018-2025
Figure 7.25: Global Single Cell Analysis Mass Spectrometry Market, 2018-2025
Figure 7.26: Global Single Cell Analysis Microscopy Market, 2018-2025
Figure 7.27: Global Single Cell Microfluidics Market, 2018-2025
Figure 7.28: Global Single Cell Analysis Market (Others), 2018-2025
Figure 8.1: Global Single Cell Multi-Omics Market, By Research and Academia, 2018-2025
Figure 8.2: Global Single Cell Multi-Omics Market, By Biopharmaceutical and Biotech Companies, 2018-2025
Figure 8.3: Global Single Cell Multi-Omics Market, By Hospitals, Clinics and Diagnostic Labs (Others), 2018-2025
Figure 9.1: Global Single Cell Multi-Omics Market (by Region), 2018 and 2025
Figure 9.2: Global Single Cell Multi-Omics Market (by Region), 2018-2025
Figure 9.3: Global Single Cell Multi-Omics Market Share (by Region), 2018
Figure 9.4: Global Single cell multi-omics Market Share (by Region), 2025
Figure 9.5: North America Global Single Cell Multi-Omics Market, 2018-2025
Figure 9.6: North America: Market Dynamics
Figure 9.7: North America Single Cell Multi-Omics Market (By Country), 2018-2025
Figure 9.8: The U.S. Single Cell Multi-Omics Market, 2018-2025
Figure 9.9: Canada Single Cell Multi-Omics Market, 2018-2025
Figure 9.10: Europe Single Cell Multi-Omics Market, 2018-2025
Figure 9.11: Europe: Market Dynamics
Figure 9.12: Europe Global Single Cell Multi-Omics Market (by Country), 2018-2025
Figure 9.13: Germany Single Cell Multi-Omics Market, 2018-2025
Figure 9.14: France Single Cell Multi-Omics Market, 2018-2025
Figure 9.15: The U.K. Single Cell Multi-Omics Market, 2018-2025
Figure 9.16: Italy Single Cell Multi-Omics Market, 2018-2025
Figure 9 17: Spain Single Cell Multi-Omics Market, 2018-2025
Figure 9.18: Rest-of-Europe Single Cell Multi-Omics Market, 2018-2025
Figure 9.19: Asia-Pacific Single Cell Multi-Omics Market, 2018-2025
Figure 9.20: APAC: Market Dynamics
Figure 9.21: APAC Single Cell Multi-Omics Market (by Country), 2018-2025
Figure 9.22: Japan Single Cell Multi-Omics Market, 2018-2025
Figure 9.23: Singapore Single Cell Multi-Omics Market, 2018-2025
Figure 9.24: India Single Cell Multi-Omics Market, 2018-2025
Figure 9.25: China Single Cell Multi-Omics Market, 2018-2025
Figure 9.26: South Korea Single Cell Multi-Omics Market, 2018-2025
Figure 9.27: Australia Single Cell Multi-Omics Market, 2018-2025
Figure 9.28: RoAPAC Single Cell Multi-Omics Market, 2018-2025
Figure 9.29: Latin America Single Cell Multi-Omics Market, 2018-2025
Figure 9.30: Latin America: Market Dynamics
Figure 9.31: Latin America Single Cell Multi-Omics Market (by Country), 2018-2025
Figure 9.32: Mexico Single Cell Multi-Omics Market, 2018-2025
Figure 9.33: Brazil Single Cell Multi-Omics Market, 2018-2025
Figure 9.34: Rest-of-Latin America Single Cell Multi-Omics Market, 2018-2025
Figure 9.35: RoW Single Cell Multi-Omics Market, 2018-2025
Figure 10.1: Applications of Single-Cell Multi-Omics
Figure 10.2: Global Single Cell Multi-Omics Market for Oncology Application (2018-2025)
Figure 10.3: Method for single cell RNA sequencing methods
Figure 10.4: Global Single Cell Multi-Omics Market for Immunology Application (2018-2025)
Figure 10.5: Global Single Cell Multi-Omics Market for Neurology Application (2018-2025)
Figure 10.6: Global Single Cell Multi-Omics Market for Microbiology Application (2018-2025)
Figure 10.7: Global Single Cell Multi-Omics Stem Cell Market (2018-2025)
Figure 10.8: Global Single Cell Multi-Omics Cell Biology Market (2018-2025)
Figure 10.9: Global Single Cell Multi-Omics Other Application Market (2018-2025)
Figure 11.1: Growth Share Matrix for Global Single Cell Multi-Omics Market (by Companies), 2018
Figure 11.2: Market Share Analysis for the Global Single Cell Multi-Omics Market, 2018
Figure 11.3: Components of Value Chain
Figure 11.4: Value Chain Analysis of Medical Device Industry
Figure 11.5: Supply Chain Analysis of a Medical Device Industry
Figure 12.1: Shares of Key Company Profiles
Figure 12.2: 1CellBio: SWOT Analysis
Figure 12.3: 10x Genomics Inc.: SWOT Analysis
Figure 12.4: Becton, Dickinson and Company: Overall Financials, 2016-2018
Figure 12.5: Becton, Dickinson and Company: Revenue (by Business Segment), 2015-2018
Figure 12.6: Becton, Dickinson and Company: Revenue (by Region), 2015-2018
Figure 12.7: Becton, Dickinson and Company: R&D Expenditure, 2016-2018
Figure 12.8: Becton, Dickinson and Company: SWOT Analysis
Figure 12.9: Bio-Rad Laboratories, Inc.: Overall Financials, (2016-2018)
Figure 12.10: Bio-Rad Laboratories, Inc.: Revenue (by Business Segment), 2016-2018
Figure 12.11: Bio-Rad Laboratories, Inc.: Revenue (by Region), 2016-2018
Figure 12.12: Bio-Rad Laboratories, Inc., R&D Expenditure, 2016-2018
Figure 12.13: Bio-Rad Laboratories, Inc.: SWOT Analysis
Figure 12.14: BGI: SWOT Analysis
Figure 12.15: Celsee Inc.: SWOT Analysis
Figure 12.16: Fluidigm Corporation: Overall Financials, 2016-2018
Figure 12.17: Fluidigm Corporation: Revenue (by Business Segment), 2016-2018
Figure 12.18: Fluidigm Corporation: Revenue (by Region), 2016-2018
Figure 12.19: Fluidigm Corporation: R&D Expenditure, 2016-2018
Figure 12.20: Fluidigm Corporation: SWOT Analysis
Figure 12.21: Fluxion Biosciences: SWOT Analysis
Figure 12.22: GE: Revenue (by Business Segment), 2015-2018
Figure 12.23: GE: Revenue (Healthcare), 2016-2018
Figure 12.24: GE Healthcare: Revenue (by Business Segment), 2015-2018
Figure 12.25: GE: R&D Expenditure, 2016-2018
Figure 12.26: GE: R&D Expenditure (By Segment), 2015-2018
Figure 12.27: GE: Overall Financials, (2016-2018)
Figure 12.28: GE: Revenue (by Business Segment), 2016-2018
Figure 12.29: GE: Revenue (Healthcare), 2016-2018
Figure 12.30: GE Healthcare: Revenue (by Business Segment), 2016-2018
Figure 12.31: GE: R&D Expenditure, 2016-2018
Figure 12.32: GE: R&D Expenditure (By Segment), 2016-2018
Figure 12.33: GE: SWOT Analysis
Figure 12.34: Mission Bio: SWOT Analysis
Figure 12.35: NanoString Technologies, Inc.: Overall Financials, (2016-2018)
Figure 12.36: NanoString Technologies, Inc.: Revenue (by Business Segment), 2016-2018
Figure 12.37: NanoString Technologies, Inc.: Revenue (by Region), 2016-2018
Figure 12.38: NanoString Technologies, Inc.: R&D Expenditure, 2016-2018
Figure 12.39: NanoString Technologies, Inc.: R&D Expenditure (By Functional Area), 2016-2018
Figure 12.40: NanoString Technologies: SWOT Analysis
Figure 12.41: Illumina Inc.: Overall Financials, (2016-2018)
Figure 12.42: Illumina, Inc.: Revenue (by Business Segment), 2016-2018
Figure 12.43: Illumina, Inc.: Revenue (by Region), 2016-2018
Figure 12.44: Illumina, Inc., R&D Expenditure, 2016-2018
Figure 12.45: Illumina, Inc. SWOT Analysis
Figure 12.46: Perkin Elmer, Inc.: Overall Financials, (2016-2018)
Figure 12.47: Perkin Elmer, Inc.: Revenue (by Business Segment), 2016-2018
Figure 12.48: Perkin Elmer, Inc.: Revenue (by Region), 2016-2018
Figure 12.49: PerkinElmer, Inc., Inc.: R&D Expenditure, 2016-2018
Figure 12.50: PerkinElmer, Inc.: SWOT Analysis
Figure 12.51: QIAGEN N.V..: Overall Financials, (2015-2017)
Figure 12.52: QIAGEN N.V.: Revenue (by Business Segment), 2015-2017
Figure 12.53: QIAGEN N.V.: Revenue (by Region), 2015-2017
Figure 12.54: QIAGEN N.V.: R&D Expenditure, 2015-2017
Figure 12.55: QIAGEN N.V.: SWOT Analysis
Figure 12.56: Takara Bio Inc.: Overall Financials, (2016-2018)
Figure 12.57: Takara Bio, Inc.: Revenue (by Business Segment), 2016-2018
Figure 12.58: Takara Bio, Inc.: Revenue (by Region), 2017
Figure 12.59: Takara Bio, Inc., R&D Expenditure, 2015-2017
Figure 12.60: Takara Bio Inc.: SWOT Analysis
Figure 13.1: Global Single Cell Multi-Omics Market Segmentation
Figure 13.2: Global Single Cell Multi-Omics Market Research Methodology
Figure 13.3: Primary Research
Figure 13.4: Secondary Research
Figure 13.5: Data Triangulation
Figure 13.6: Bottom-up Approach (Segment-wise Analysis)
Figure 13.7: Top-down Approach (Segment-wise Analysis)
Figure 13.8: Assumptions and Limitations
Figure 13.9: Considered Factors for Data Prediction and Modeling
